Central Idea

India has recently become a member of the Centralized Laboratory Network (CLN), which is a part of the Coalition for Epidemic Preparedness Innovations (CEPI).

Centralised Laboratory Network (CLN)

CLN consists of 15 partner facilities in 13 countries and aims to test vaccines for use during pandemics and epidemic disease outbreaks.
It focuses on testing vaccines for pandemic and epidemic disease outbreaks.
It is part of the Coalition for Epidemic Preparedness Innovations (CEPI).
The network aims to standardize testing methods and materials.

Indian Council of Medical Research-National Institute of Virology (ICMR-NIV) joins CLN.
Institute Pasteur de Dakar (IPD) from Senegal is a new member.
KAVI Institute of Clinical Research (KAVI ICR) and University of Nairobi Institute of Tropical and Infectious Diseases (UNITID) from Kenya join CLN.
Synexa Life Sciences from South Africa becomes a member.
Uganda Virus Research Institute (UVRI) from Uganda is also a new member.

The CEPI-funded network aims to identify promising vaccine candidates rapidly and accurately.
The network focuses on emerging infectious diseases.
The goal is to support sustainable regional outbreak preparedness infrastructure.

The CEPI-funded network, which includes CLN, has the primary objective of identifying the most promising vaccine candidates rapidly and accurately against emerging infectious diseases.
In addition to vaccine testing, the expanded network also aims to support the development of sustainable regional outbreak preparedness infrastructure.
By working collaboratively and sharing standardized methods and materials, the network enhances global preparedness for potential disease outbreaks.